Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Oken

Showing results (101-110 of 148) with videos related to

Pageof 15
Sort By:
Journal of Pain and Symptom Management|April 1, 1997
Improving cancer pain management in communities: main results from a randomized controlled trialT E Elliott, D M Murray, M M Oken, et al.
Investigational New Drugs|May 1, 1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancerD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.
Leukemia|August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)C Robles, K M Kim, M M Oken, et al.
Journal of Pain and Symptom Management|October 1, 1995
Physician knowledge and attitudes about cancer pain management: a survey from the Minnesota cancer pain projectT E Elliott, D M Murray, B A Elliott, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.
Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.
Blood|October 1, 1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialP Liu, T Leong, L Quam, et al.
Leukemia & Lymphoma|February 1, 1996
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myelomaM M Oken, R A Kyle, P R Greipp, et al.
Pageof 15

Showing results (101-110 of 148) with videos related to

Sort By:
Pageof 15
Journal of Pain and Symptom Management|April 1, 1997
Improving cancer pain management in communities: main results from a randomized controlled trialT E Elliott, D M Murray, M M Oken, et al.
Investigational New Drugs|May 1, 1990
Phase II study of n-methylformamide (NSC 3051) and spirogermanium (NSC 192965) in the treatment of advanced small cell lung cancerD S Ettinger, D M Finkelstein, M D Abeloff, et al.
Leukemia|October 1, 1992
Phase II clinical trial of carboplatin in relapsed and refractory leukemiaW R Vogler, D P Harrington, E F Winton, et al.
Leukemia|August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)C Robles, K M Kim, M M Oken, et al.
Journal of Pain and Symptom Management|October 1, 1995
Physician knowledge and attitudes about cancer pain management: a survey from the Minnesota cancer pain projectT E Elliott, D M Murray, B A Elliott, et al.
British Journal of Haematology|June 10, 2000
Prognostic value of serum markers of bone metabolism in untreated multiple myeloma patientsR Fonseca, M C Trendle, T Leong, et al.
Leukemia & Lymphoma|June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)P H Wiernik, T Leong, M M Oken, et al.
Investigational New Drugs|January 1, 1995
A phase II study of interleukin-2 with and without beta-interferon in the treatment of advanced renal cell carcinomaR S Witte, T Leong, M S Ernstoff, et al.
Blood|October 1, 1996
Activating mutations of N- and K-ras in multiple myeloma show different clinical associations: analysis of the Eastern Cooperative Oncology Group Phase III TrialP Liu, T Leong, L Quam, et al.
Leukemia & Lymphoma|February 1, 1996
Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myelomaM M Oken, R A Kyle, P R Greipp, et al.
Pageof 15